Assignee
SINOMAB BIOSCIENCE LTD
CN·4 granted patents·5 pending applications·8 citations·filing 2013–2024
Top patents by PatentIndex Score
9 records- 0189US9371396B2Anti-CD22 anti-idiotypic antibodies and uses thereofSINOMAB BIOSCIENCE LTD·Filed 2013·Granted Jun 21, 2016·8 cites·2 claims
- 0277US2025136683A1Method of modulating autoimmunity by disrupting cis-ligand binding of siglec type antigensSINOMAB BIOSCIENCE LTD·Filed 2024·Application pending·0 cites
- 0373US12173065B2Fusion proteins comprising extracellular domain of human CD22SINOMAB BIOSCIENCE LTD·Filed 2019·Granted Dec 24, 2024·0 cites·12 claims
- 0466US2024409647A1Bispecific binding proteins against alarmins and uses thereofSINOMAB BIOSCIENCE LTD·Filed 2024·Application pending·0 cites
- 0564US2025282852A1Methods of treating neurological diseasesSINOMAB BIOSCIENCE LTD·Filed 2023·Application pending·0 cites
- 0661US2024309089A1Methods of treating neurological diseasesSINOMAB BIOSCIENCE LTD·Filed 2022·Application pending·0 cites
- 0757US10613099B2Cell lines expressing surface bound anti-idiotype antibodies against anti-CD22 antibodies and uses thereofSINOMAB BIOSCIENCE LTD·Filed 2016·Granted Apr 7, 2020·0 cites·14 claims
- 0857US2024409631A1Aqueous formulations of an anti-cd22 antibody and uses thereofSINOMAB BIOSCIENCE LTD·Filed 2022·Application pending·0 cites
- 0948US11180475B2Crystal form I of a 5-aminopyrazole carboxamide compound as BTK inhibitorSINOMAB BIOSCIENCE LTD·Filed 2018·Granted Nov 23, 2021·0 cites·7 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →